Connection
Jenna Burton to Antineoplastic Combined Chemotherapy Protocols
This is a "connection" page, showing publications Jenna Burton has written about Antineoplastic Combined Chemotherapy Protocols.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.189 |
|
|
|
-
Parker AS, Burton JH, Curran KM, Wolf-Ringwall A, Thamm DH. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma. J Vet Intern Med. 2024 Jul-Aug; 38(4):2282-2292.
Score: 0.104
-
Curran KM, Schaffer PA, Frank CB, Lana SE, Hamil LE, Burton JH, Labadie J, Ehrhart EJ, Avery PR. BCL2 and MYC are expressed at high levels in canine diffuse large B-cell lymphoma but are not predictive for outcome in dogs treated with CHOP chemotherapy. Vet Comp Oncol. 2017 Dec; 15(4):1269-1279.
Score: 0.060
-
Burge R, Woolard KD, Willcox JL, Rebhun RB, Burton JH, Al-Nadaf S, Skorupski KA. High-Grade, Stage 2 Mast Cell Tumors: Outcome in Dogs With Local and Systemic Therapy. J Am Anim Hosp Assoc. 2023 Jul 01; 59(4):167-176.
Score: 0.024